Qualigen therapeutics, inc. announces closing of $3.47 million public offering

Carlsbad, calif., sept. 06, 2024 (globe newswire) -- qualigen therapeutics, inc. (nasdaq: qlgn) (the “company”) today announced the closing of its previously announced public offering of 14,724,058 shares of common stock, par value $0.001 per share (each a “share,” and collectively, the “shares”) at public offering price of $0.13 per share and pre-funded warrants to purchase up to 11,972,754 shares at a price of $0.129 per share with an exercise price of $0.001 per share (the “pre-funded warrants”). the pre-funded warrants are exercisable upon issuance and will remain exercisable until all the pre-funded warrants are exercised in full.
QLGN Ratings Summary
QLGN Quant Ranking